Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1975 Oct;183(2):229-41.
doi: 10.1002/ar.1091830202.

The effects of prostaglandin F2alpha on the fine structure of the corpus luteum of the hysterectomized guina pig

The effects of prostaglandin F2alpha on the fine structure of the corpus luteum of the hysterectomized guina pig

J N Bagwell et al. Anat Rec. 1975 Oct.

Abstract

Luteal cell fine structure was studied in hysterectomized control and hysterectomized, prostaglandin-treated (1-5 days) guinea pigs. In hysterectomized control animals, luteal cells were hypertrophied and were characterized by an abundance of agranular endoplasmic reticulum (AER) suggesting steroidogenic activity. With one day of prostaglandin treatment, little change in the cytological appearance had occurred. After two, or three days of treatment, cells showed a decrease in size and an apparent increase in the number of lipid droplets. Following four days of prostaglandin treatment, luteal tissue was characterized by the presence of large amounts of collagen in the intercellular spaces and by the invasion of fibroblasts. Areas of degenerating luteal cells with numerous myelin figures and lipid droplets were observed. After five days of prostaglandin treatment, most of the luteal cells had undergone extensive luteolytic changes. Typically they contained coalescing lipid droplets, myelin figures and crystalloids, and were surrounded by collagen fibers. These observation suggest that prostaglandin F2alpha does effect structural luteolysis in this species in the absence of uterine tissue.

PubMed Disclaimer

Substances

LinkOut - more resources